v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net (loss) income $ 1,748 $ 9,734 $ 14,948
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, depletion and amortization 29,972 23,515 21,158
(Benefit) provision for deferred income taxes (4,278) 804 1,876
Stock-based compensation 4,444 9,959 8,318
Derivative mark-to-market adjustments and settlements 549 486 560
Net loss on disposal of assets 36 0 94
(Decrease) increase in earn-out liability 594 (1,703) 1,266
Accretion of asset retirement obligations 485 445 407
Liabilities associated with properties sold 0 (225) 0
Amortization of debt issuance costs 391 360 367
Impairment loss 3,231 1,586 902
Non cash expense - RINs sold from equity method investment 1,661 0 0
Income from equity method investment (1,485) 0 0
Accounts receivable (995) 4,580 (5,531)
Royalty offset long term receivable (4,595) (3,089) (3,515)
Income tax receivable (661) (354) (89)
Critical spare inventory (1,694) 472 (1,012)
Accounts payable and Accrued liabilities 735 (2,298) 1,326
Other 196 (477) (22)
Net cash provided by operating activities 30,334 43,795 41,053
Cash flows from investing activities      
Capital expenditures (116,542) (62,323) (63,091)
Asset acquisition 0 (820) 0
Capital contributions to equity method investments (4,000) 0 0
Cash collateral deposits 55 (48) 2
Proceeds from sale of assets 0 1,000 2
Net cash used in investing activities (120,487) (62,191) (63,087)
Cash flows from financing activities:      
Repayments of long-term debt (12,000) (8,000) (8,000)
Borrowings on revolver 105,000 0 0
Repayments on revolver (20,000) 0 0
Contingent consideration payments (4,176) 0 0
Common stock issuance 5 6 4
Treasury stock purchase (419) (1,780) (122)
Related party receivable 0 0 (1,138)
Finance lease payments (71) (68) (74)
Net cash provided (used) in financing activities 68,339 (9,842) (9,330)
Net decrease in cash and cash equivalents and restricted cash (21,814) (28,238) (31,364)
Cash and cash equivalents and restricted cash at beginning of period 46,004 74,242 105,606
Cash and cash equivalents and restricted cash at end of period 24,190 46,004 74,242
Reconciliation of cash, cash equivalents, and restricted cash at end of period:      
Cash and cash equivalents 23,752 45,621 73,811
Restricted cash and cash equivalents - current 8 8 8
Restricted cash and cash equivalents - non-current 430 375 423
Reconciliation of cash, cash equivalents, and restricted cash at end of year 24,190 46,004 74,242
Supplemental cash flow information:      
Cash paid for interest, net of $1,308 and $0 capitalized respectively 4,058 4,300 5,003
Cash paid for income taxes 783 1,993 1,915
Accrual for purchase of property, plant and equipment included in accounts payable and accrued liabilities 11,785 4,699 5,471
Non-cash purchase of Treasury stock 0 8,309 0
Non-cash RIN distribution from equity method investment $ 1,661 $ 0 $ 0